Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1115 | 975 | 1115 | 1101 | 1246 | 1648 |
Fund Return | 11.53% | -2.45% | 11.53% | 3.26% | 4.5% | 5.12% |
Place in category | 208 | 615 | 208 | 696 | 1054 | 611 |
% in Category | 9 | 28 | 9 | 39 | 69 | 64 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Invesco Japanese Equity Advantage a | 68.9B | 8.06 | -0.30 | 6.63 | ||
Invesco Japanese Equity Advantage e | 68.9B | 7.54 | -0.90 | 5.95 | ||
Invesco Japanese Equity Advantage z | 68.85B | 8.94 | 0.50 | 7.47 | ||
Invesco JapEqAdvantage A EUR H AccE | 68.85B | 15.41 | 9.09 | 7.73 | ||
Invesco JapEqAdvantage C EUR H AccE | 68.85B | 16.34 | 10.03 | 8.58 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
European Growth Fund A Acc EUR | 164.37M | 15.77 | 4.40 | 5.61 | ||
European Growth Fund E Acc EUR | 7.13B | 14.87 | 3.61 | 4.82 | ||
European Growth Fund Y Acc EUR | 260.01M | 16.70 | 5.28 | 6.49 | ||
European Growth Fund Y DIST EUR | 7.13B | 16.70 | 5.28 | 6.49 | ||
European Growth Fund A DIST Eue | 7.13B | 15.73 | 4.38 | 5.61 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novartis | CH0012005267 | 2.35 | 90.26 | 0.00% | |
SAP | DE0007164600 | 1.80 | 263.550 | +0.44% | |
Danone | FR0000120644 | 1.79 | 64.94 | -0.15% | |
Roche Holding Participation | CH0012032048 | 1.74 | 274.90 | +0.18% | |
Unilever | GB00B10RZP78 | 1.74 | 53.96 | -0.92% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review